Medtronic Bone Graft Reimbursement Fate Fused With Stryker’s In CMS Rule

CMS' proposed decision to deny a new-technology add-on to Medtronic's InFuse bone graft reaffirms that "substantial clinical improvement" ranks last in the hierarchy of evidence required for the payment